Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;36(2):569-572.
doi: 10.1038/s41375-021-01447-3. Epub 2021 Oct 8.

Normal life expectancy for polycythemia vera (PV) patients is possible

Ghaith Abu-Zeinah  1 , Richard T Silver  2 , Khalid Abu-Zeinah  3 , Joseph M Scandura  2
Affiliations

Normal life expectancy for polycythemia vera (PV) patients is possible

Ghaith Abu-Zeinah et al. Leukemia. 2022 Feb.
No abstract available

PubMed Disclaimer

References

    1. Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376:2168–81. - DOI
    1. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 1986;23:132–43. - PubMed
    1. Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, et al. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368:22–33. - DOI
    1. Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N. Engl J Med. 2004;350:114–24. - DOI
    1. Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, et al. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European. LeukemiaNet Leuk. 2018;32:1057–69. - DOI

Publication types

LinkOut - more resources